Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Scotiabank from $43.00 to $48.00. They now have a "sector outperform" rating on the stock.
Earnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts [Yahoo! Finance]
Twist Bioscience: NGS Is Taking Off [Seeking Alpha]
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Evercore ISI from $46.00 to $50.00. They now have an "outperform" rating on the stock.